Teva Pharmaceutical Industries Limited
TEVJF
$37.00
$8.6030.28%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -256.10% | -23.13% | 10.85% | 53.55% | 31.78% |
| Total Depreciation and Amortization | 0.84% | -8.08% | 4.42% | -0.80% | 2.87% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3,035.48% | -116.40% | -23.79% | 726.67% | -78.10% |
| Change in Net Operating Assets | 73.42% | -369.43% | 140.82% | -66.96% | 52.00% |
| Cash from Operations | 1,127.50% | -103.45% | 213.82% | 62.56% | 316.19% |
| Capital Expenditure | 38.10% | -18.31% | -4.41% | -41.67% | 24.41% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -90.48% | -- | -100.00% | -11.11% | -47.06% |
| Other Investing Activities | -14.08% | 15.64% | 16.73% | -18.58% | 3.86% |
| Cash from Investing | -314.41% | 38.79% | 22.22% | -42.80% | 17.41% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 100.00% | 80.39% | -68.13% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -102.78% | -10.00% | 2,100.00% | -300.00% | 100.27% |
| Cash from Financing | -107.69% | -67.50% | 108.83% | -7,650.00% | 100.34% |
| Foreign Exchange rate Adjustments | 70.59% | -70.00% | -11.11% | -80.00% | -111.11% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -146.49% | -86.33% | 3,121.43% | -90.95% | 128.95% |